Phase 2/3RecruitingNCT06387199
Semaglutide to reduce carb-counting burden on closed loop
McGill 2x4 factorial trial testing weekly semaglutide plus simplified meal strategies in people with T1D using closed-loop insulin therapy.
Primary endpoints
- Daytime glucose time in range for semaglutide versus placebo
Results so far
No results posted yet.